Today: 7 February 2026
Subscribe
Browse Category

Mergers & Acquisitions News 21 October 2025 - 27 October 2025

Huntington’s $7.4B Texas-Tupelo Power Move: Cadence Bank Takeover Shakes Up Banking

Huntington’s $7.4B Texas-Tupelo Power Move: Cadence Bank Takeover Shakes Up Banking

Deal Details and Rationale On Oct. 27, Huntington Bancshares announced it will absorb Cadence Bank in a stock-for-stock merger finimize.com sec.gov. Cadence is a $53 billion-asset regional bank based in Houston/Tupelo, with 390 branches in eight states sec.gov bankingdive.com. Under the deal Huntington will issue 2.475 of its shares per Cadence share. Based on HBAN’s Oct. 24 close of $16.07, the exchange price equals $39.77 per Cadence share (a ~9% premium) finimize.com bankingdive.com. This values Cadence at $7.4 billion in total finimize.com bankingdive.com. The combined bank will have about $276 billion in assets, $220 billion in deposits, and $184 billion in loans and leases reuters.com bankingdive.com.
27 October 2025
··
RNA Stock Skyrockets: Avidity Biosciences Soars on $12B Novartis Buyout and Breakthrough Trials

RNA Stock Skyrockets: Avidity Biosciences Soars on $12B Novartis Buyout and Breakthrough Trials

Stock Performance & Recent Trends Prior to the buyout news, RNA stock had been on a steady uptrend in 2025. The share price more than doubled from the low-$20s a year ago to the high-$40s this month ts2.tech. In the past three months alone, RNA jumped ~40%, fueled by upbeat clinical updates and M&A speculation ts2.tech. The stock hit a 52-week peak of $56 in early October ts2.tech after its lead DMD therapy showed strong results and secured FDA Breakthrough designation. Shares pulled back slightly to around $49 by late October, but remained up 100%+ year-over-year ts2.tech. A major catalyst
27 October 2025
······
Novartis’ $12B Biotech Buyout Shakes Up Avidity Biosciences (RNA) – Is the Rare-Disease Stock Set to Soar?

Novartis’ $12B Biotech Buyout Shakes Up Avidity Biosciences (RNA) – Is the Rare-Disease Stock Set to Soar?

Bottom Line: Avidity Biosciences’ stock is set to explode higher on Novartis’s $12 billion buyout, capping off a dramatic run fueled by breakthrough science and takeover buzz. The high-premium deal underscores the massive value of RNA therapeutics for rare diseases – and signals that big pharma’s biotech spending spree isn’t slowing down. While Avidity’s chapter as an independent company is closing, its novel treatments may reach patients faster under Novartis’s umbrella. Investors now await the finalization of the deal (and SpinCo details), as Wall Street cheers another biotech success story in the making. 🏥💥 Sources: reuters.comreuters.combusiness-standard.combiospace.combiospace.commarketbeat.comts2.techmarketbeat.comsahmcapital.comsahmcapital.combiospace.combiospace.combusiness-standard.comreuters.combusiness-standard.comreuters.comreuters.comts2.techts2.techbiospace.combiospace.combiospace.combiospace.com
26 October 2025
···
DraftKings Bets Big: Railbird Acquisition and NBC Deal Ignite Investor Frenzy

DraftKings Bets Big: Railbird Acquisition and NBC Deal Ignite Investor Frenzy

Record Revenue, Rising Margins Drive Optimism In early August, DraftKings reported blowout Q2 results – revenue of $1.51 billion (up 37% YoY) and adjusted EBITDA of $301 million, more than double the prior recordinvesting.com. Management noted strong sportsbook hold and growth in monthly active users. CEO Jason Robins said, “We set records for revenue, net income and Adjusted EBITDA in the second quarter”investing.com. The company reaffirmed its full-year outlook, expecting to hit the high end of $6.2–6.4B revenue and roughly $850M EBITDAinvesting.com. The upbeat results lifted DraftKings shares (they rose ~4% immediately after releaseinvesting.com) and helped narrow the gap with archrival FanDuel
25 October 2025
···
Luminar (LAZR) Stock Surges on Lidar Hype – Volvo & NVIDIA Deals Ignite Investor Interest

Luminar Stock Skyrockets 31% on Buyout Buzz – Lidar Boom Back in Spotlight?

Luminar’s LiDAR technology has gained attention as its stock popped in late October 2025. Investors are weighing the firm’s strong auto partnerships against its slim revenue base and recent buyout proposal. Stock Rally and Buyout Speculation Luminar Technologies, a Florida-based maker of long-range automotive LiDAR, has suddenly found itself in the headlines. On Oct. 25, 2025, Luminar’s stock jumped about 31% to roughly $2.22reuters.com. This surge came amid two key catalysts: a broad tech stock rally and speculation around founder Austin Russell’s plans. According to an SEC filing and media reports, Russell – who was ousted as CEO in May
25 October 2025
····
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr (GRND) Stock Explodes on $18 Buyout Buzz – Is a $3.5B Takeover Coming?

Stock Reaction and Trading Activity On Friday Oct 24, GRND shot up from the low-$12 range into the mid-$15s. Finviz data show Friday’s prevailing price was $12.67 with the stock closing at $15.06 (a +18.86% jump)finviz.com. Investing.com and TechStock² report intraday spikes to ~$16 (after the $18 bid was revealed) before settling near $15ts2.techinvesting.com. Trading volume was ~11.4 M shares on Friday – roughly five times the 6-week average – reflecting the frenzied demandfinviz.com. In short, the buyout news sent GRND soaring. By contrast, peers like Bumble and Match saw only modest moves. (Note: U.S. markets were closed on Saturday 10/25, so
25 October 2025
····
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Buyout Buzz Sends GRND Soaring Grindr’s stock price skyrocketed after news of a potential insider buyout broke. On Friday, Oct. 24, GRND opened at $14.50 and surged as high as $16.22 intraday, an approximately 25% jump from the prior day’s closeinvesting.com. The rally came after Grindr confirmed that its two largest shareholders – board Chair James Fu Bin Lu and director G. Raymond Zage III – had submitted a preliminary proposal to take the company private at $18.00 per share in cashd18rn0p25nwr6d.cloudfront.netd18rn0p25nwr6d.cloudfront.net. By the end of the day, Grindr stock was hovering around $15.90 (up ~25.6%) on heavy volumebarchart.com, as
24 October 2025
···
Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Stock Price Rallies Amid Mortgage Market Shifts Rocket Companies’ stock has been on a wild ride this year. As of Oct. 24, RKT was trading around $16.94-$17 per sharegoogle.com – roughly flat on the day after some early swings (intraday high ~$17.10, low ~$16.41)google.com. That price is about 70-80% higher than where it started 2025, making Rocket a standout gainer in an otherwise sluggish housing sectoryoutube.com. The stock reached as high as the low-$20s in early October, when excitement over Rocket’s latest acquisition peaked, before cooling off. In fact, RKT shares have climbed about 54% since late March (when its
24 October 2025
···
Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Alkermes Buyout Sparks Rally in AVDL Stock On Oct. 22, 2025, Alkermes announced it would acquire Avadel for $18.50 cash per share plus a $1.50 contingent value right (CVR) tied to an FDA approval for idiopathic hypersomnia, valuing the deal at up to $2.1 billion prnewswire.com. The all-cash offer represents roughly a 12% premium to Avadel’s recent trading range. Avadel CEO Greg Divis hailed the terms as “a compelling outcome for our shareholders” prnewswire.com, while Alkermes CEO Richard Pops said the deal is “a pivotal step” to accelerate Alkermes’ entry into the sleep-medicine market prnewswire.com. Avadel’s board and Alkermes’ board have
22 October 2025
····
Warner Bros Discovery Stock Skyrockets on $60B Takeover Rumors

Warner Bros Discovery Stock Skyrockets on $60B Takeover Rumors

Shares Surge Amid Takeover Buzz On Oct. 21, Warner Bros Discovery officially confirmed that it was exploring “strategic alternatives” after fielding takeover inquiries theguardian.com reuters.com. In a press release, WBD said it had received “unsolicited interest…from multiple parties for both the entire company and Warner Bros.” theguardian.com. The news ignited a buying frenzy: WBD stock jumped from around $18.30 before the announcement to about $20 by the day’s end ts2.tech reuters.com. In dollar terms that was roughly an 11% one-day gain reuters.com, adding to an already massive rally this year (shares are up roughly 75% since Jan. 1 ts2.tech). The
22 October 2025
····
Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Deal Details and Company Background Hologic (NYSE: HOLX) is a Marlborough, MA–based medical technology firm focused on women’s health. Its products include mammography and breast biopsy systems, cervical cancer tests, surgical equipment (notably after its acquisition of Gynesonics), and lab diagnostics including molecular tests for Covid-19 bostonglobe.com. The Blackstone/TPG consortium will buy all outstanding Hologic shares for $76 cash plus a $3 CVR (contingent on hitting revenue goals in 2026–27 for the breast health business) marketscreener.com. This values the deal at $79 per share maximum and around $18.3 billion total enterprise value marketscreener.com. The purchase price represents a roughly 46%
21 October 2025
···
1 … 27 28 29 30 31 … 34

Stock Market Today

Lloyds share price steadies after buyback update and BoE rate jitters — what to watch next week

Lloyds share price steadies after buyback update and BoE rate jitters — what to watch next week

7 February 2026
LONDON, February 7, 2026, 08:48 GMT — Market closed Lloyds Banking Group shares finished Friday higher after the lender flagged another round of share buybacks, helping to steady the stock at the end of a volatile two-day swing driven by shifting expectations for UK interest rates. With London markets closed for the weekend, the focus moves to Monday’s open and whether rate-cut pricing keeps easing pressure on bank earnings. Lloyds is a UK-focused lender, and investors tend to treat it as a clean play on domestic growth, mortgages and the direction of Bank Rate. That makes the stock quick to
Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

7 February 2026
Vodafone shares rose 1.47% to 110.60p Friday, recovering part of Thursday’s 4.68% drop after a Q3 update. Group revenue climbed 6.5% to €10.5 billion, but Germany’s 0.7% service revenue growth missed some forecasts. Vodafone launched a new €500 million buyback tranche, bringing total buybacks since May to €3.5 billion. Investors remain focused on Germany’s pace and cash flow execution.
NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
Go toTop